Canopy Growth to Announce Fourth Quarter and Fiscal Year 2019 Financial Results

Canopy Growth to Announce Fourth Quarter

and Fiscal Year 2019 Financial Results

SMITHS FALLS, ON, June 7, 2019 /CNW/ - Canopy

Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NYSE: CGC) will release its financial results

for the fourth quarter and fiscal year ended March 31, 2019 after financial markets close on June 20, 2019.

Canopy Growth to Announce Fourth Quarter and

Fiscal Year 2019 Financial Results (CNW Group/Canopy Growth Corporation)

Following the release of its fourth quarter

and fiscal year 2019 financial results, Canopy Growth will host a conference call and audio webcast with Bruce Linton, Chairman

& Co-CEO and Mike Lee, EVP & CFO at 8:30 AM Eastern Time on June 21, 2019.

A live audio webcast will be available at:

Toll Free Dial-In Number: 1-888-231-8191

International Dial-In Number: (647) 427-7450

Conference ID: 4338214

A replay of the call will be accessible by telephone until 11:59 PM ET on September 21, 2019.

Toll Free Dial-in Number: 1-855-859-2056

Replay Password: 4338214

About Canopy Growth Corporation

Canopy Growth (TSX:WEED, NYSE:CGC) is a world-leading diversified cannabis, hemp and cannabis device company, offering distinct

brands and curated cannabis varieties in dried, oil and Softgel capsule forms, as well as medical devices through the Company's

subsidiary, Storz & Bickel GMbH & Co. KG. From product and process innovation to market execution, Canopy Growth is driven

by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time.

The Company has operations in over a dozen countries across five continents.

The Company's medical division, Spectrum Therapeutics

is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public's understanding

of cannabis, and has devoted millions of dollars toward cutting edge, commercializable research and IP development. Spectrum Therapeutics

sells a range of full-spectrum products using its colour-coded classification Spectrum system as well as single cannabinoid Dronabinol

under the brand Bionorica Ethics.

The Company operates retail stores across Canada

under its award-winning Tweed and Tokyo Smoke banners. Tweed is a globally recognized cannabis brand which has built a large and

loyal following by focusing on quality products and meaningful customer relationships.

From our historic public listing on the Toronto

Stock Exchange and New York Stock Exchange to our continued international expansion, pride in advancing shareholder value through

leadership is engrained in all we do at Canopy Growth. Canopy Growth has established partnerships with leading sector names including

cannabis icons Snoop Dogg and Seth Rogen, breeding legends DNA Genetics and Green House Seeds, and Fortune 500 alcohol leader Constellation

Brands, to name but a few. Canopy Growth operates eleven licensed cannabis production sites with over 4.7 million square feet of

production capacity, including over one million square feet of GMP certified production space. For more information visit www.canopygrowth.com

Notice Regarding Forward Looking Statements

This news release contains "forward-looking statements" within the meaning of the United States Private Securities Litigation

Reform Act of 1995 and "forward-looking information" within the meaning of applicable Canadian securities legislation.

Often, but not always, forward-looking statements and information can be identified by the use of words such as "plans",

"expects" or "does not expect", "is expected", "estimates", "intends", "anticipates"

or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions,

events or results "may", "could", "would", "might" or "will" be taken, occur

or be achieved. Forward-looking statements or information involve known and unknown risks, uncertainties and other factors which

may cause the actual results, performance or achievements of Canopy Growth or its subsidiaries to be materially different from

any future results, performance or achievements expressed or implied by the forward-looking statements or information contained

in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events,

results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking

information, including the Company's ability to satisfy provincial sales contracts or provinces purchasing all cannabis allocated

to them, and such risks contained in the Company's annual information form dated June 27, 2018 and filed with Canadian securities

regulators available on the Company's issuer profile on SEDAR at www.sedar.com. Although the Company believes that the assumptions

and factors used in preparing the forward-looking information or forward-looking statements in this news release are reasonable,

undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed

time frames or at all. The forward-looking information and forward-looking statements included in this news release are made as

of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking information

or forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities

original content to download multimedia:http://www.prnewswire.com/news-releases/canopy-growth-to-announce-fourth-quarter-and-fiscal-year-2019-financial-results-300864122.html

SOURCE Canopy Growth Corporation

View original content to download multimedia:

For further information: Caitlin O'Hara, Media Relations,

Caitlin.Ohara@canopygrowth.com, 613-291-3239; Investor Relations, Tyler Burns, Tyler.Burns@canopygrowth.com, 855-558-9333 ext.

CO: Canopy Growth Corporation

CNW 17:36e 07-JUN-19